Search Thermo Fisher Scientific
Guide clinical decision making with molecular diagnostics
An educational resource page
Working together with laboratories, Thermo Fisher Scientific played a critical role in helping to solve the world’s greatest challenges during the COVID‑19 pandemic. As a leader in the industry, we will continue to be here for you—delivering trusted molecular diagnostic solutions that help you guide effective patient outcomes.
Laboratories around the world invested billions in resources to support molecular testing for SARS-CoV-2, but the value of these tests will make a significant impact on global health beyond the pandemic. Molecular testing enables accurate and actionable results that can enhance the quality of patient care and shape the future for healthcare best practices.
While traditional methods, such as culture, continue to have an important role in diagnosis of infectious diseases, PCR technology has clinical evidence to support improved patient outcomes. The technology is substantial, running thousands of highly sensitive samples with same day results.
Explore the resources below to learn more about the role molecular testing can serve in patient management and care decisions.
Panel discussions: “Diagnostics- fulfilling its potential”
In this 3-part educational series hosted in collaboration with Arizona State University, leading national experts in the chosen topics tackle the important challenges surrounding when, how, and why to use diagnostics to improve the current healthcare system.
Recent articles featuring our Medical and Scientific Affairs team
Educational resources by disease and focus areas
Respiratory tract infections
Molecular testing has improved diagnosis of circulating respiratory viruses and atypical bacteria.
Learn more ›
Request RTI infographic ›
Urinary tract infections
Discover how to use PCR for the detection of urinary tract infections and the growing evidence for this molecular testing method.
Gastrointestinal tract infections
There are challenges in diagnosing infectious gastroenteritis. Molecular testing can enable laboratories to address those challenges.
Learn more ›
Request GI infographic ›
Sexually transmitted/Vaginal infections
Early and accurate detection and differentiation is the first step toward understanding the cause of infection and determining next steps.
Learn more ›
Request STI infographic ›
Request VM infographic ›
Viral hepatitis molecular testing
Molecular diagnostic testing for viral hepatitis can be used to confirm hepatitis infection when serology results are unclear, and to monitor viral load levels.
HIV molecular testing
Explore how molecular genomic and genetic testing serve as powerful tools in the global fight to end HIV.
Antibiotic resistance
Next step for Molecular Diagnostics and Antimicrobial Resistance: How to Maximize Advanced Technology in the Lab.
Watch webinar ›
eBook and learning guides
e-Book: The value of molecular testing
A compilation of informative interviews with key medical experts, this is intended to aid lab professionals and clinicians working in all types of laboratories to better understand the clinical value of molecular testing.
Respiratory Tract Infections Learning Guide
This comprehensive review of viral, bacterial, fungal, and parasitic RTIs is divided into four chapters.
HIV Learning Guide: A Primer for Healthcare Professionals
This comprehensive HIV learning guide is offered with case studies in four modules and is edited by HIV healthcare experts from Senegal, Nigeria, India, and Brazil.
Blogs, articles, and white papers
Key Considerations for Using Stool Culture to PCR for GI Testing
Advanced molecular testing, such as PCR, offers significant benefits for patients, clinicians, and lab professionals alike.
The Health Benefits and Economic Value of Pharmacogenomics
PGx is a core element of precision medicine and is designed to improve the individual’s response to medication by assessing drug-compatibilities with the person’s genomic profile.
Infectious Gastroenteritis: Molecular Testing to Get Ahead of Outbreaks
An overview of the many potential causes of infectious gastroenteritis and why molecular testing is critical to help differentiate.
The concept of clinical utility for diagnostic tests
What is clinical utility? Clinical utility defines the likelihood of the test’s results to inform and support clinical decisions that improve patient outcomes. Learn more in our latest blog.
Molecular syndromic panels for infectious disease testing
This article summarizes highlights learned from syndromic panels for RTIs, UTIs, STIs, and vaginal and GI infections, and antimicrobial resistance markers.
Leveraging Syndromic Testing to Improve Patient Care
An interview with Jennifer Dien Bard, PhD
The Challenges Posed by Overutilization of Antibiotics
Health organizations have identified the growing rate of antimicrobial resistance as a global and public health concern.
Is it Time to Substitute Culture With Molecular Diagnostics?
Read why laboratories newly equipped with MDx infrastructure may be in an advantageous position to expand testing menus to include infectious diseases beyond SARS-CoV-2.
SARS-CoV-2: Mutation testing & variant surveillance
Learn how PCR genotyping can support early detection of new variants and quickly confirm viral mutation.
Style Sheet for Global Design System